Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

CEMP

Cempra (CEMP)

Cempra
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CEMP
DateHeureSourceTitreSymboleSociété
03/08/202014h00GlobeNewswire Inc.Melinta Therapeutics Announces Appointment of Christine Ann Miller as President and Chief Executive OfficerNASDAQ:CEMPCempra
07/02/201812h02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CEMPCempra
26/01/201822h47Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:CEMPCempra
22/01/201823h20Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:CEMPCempra
19/01/201823h17Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:CEMPCempra
12/01/201819h29Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CEMPCempra
11/01/201823h08Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CEMPCempra
11/01/201823h05Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CEMPCempra
10/01/201812h12Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:CEMPCempra
10/01/201800h31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CEMPCempra
09/01/201822h26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CEMPCempra
08/01/201823h21Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CEMPCempra
05/12/201723h29Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:CEMPCempra
04/12/201714h19Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CEMPCempra
16/11/201722h35Edgar (US Regulatory)Statement Regarding Change in Majority of Directors Pursuant to Rule 14f-1 (sc 14f1)NASDAQ:CEMPCempra
13/11/201723h11Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CEMPCempra
13/11/201722h39Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CEMPCempra
03/11/201716h59GlobeNewswire Inc.Cempra Announces Preliminary Results of 2017 Stockholder Vote NASDAQ:CEMPCempra
02/11/201721h22Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CEMPCempra
01/11/201712h00GlobeNewswire Inc.Melinta and Cempra Announce Accomplished Executive Leadership Team for Combined OrganizationNASDAQ:CEMPCempra
31/10/201712h00GlobeNewswire Inc.Melinta and Cempra Name Industry Leader Daniel Wechsler as President and Chief Executive Officer of the Combined CompanyNASDAQ:CEMPCempra
24/10/201714h00GlobeNewswire Inc.Melinta Therapeutics Publication Reinforces Baxdela Tolerability and Activity in Patients with MRSA Infections and Challengin...NASDAQ:CEMPCempra
10/10/201714h00GlobeNewswire Inc.Melinta Therapeutics’ Topical Radezolid Well Tolerated in Phase 1 Study for Treatment of AcneNASDAQ:CEMPCempra
05/10/201712h11Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:CEMPCempra
04/10/201719h14GlobeNewswire Inc.Melinta Therapeutics Presents Outcomes of Baxdela Treatment of Gram-Positive and Gram-Negative Pathogens at IDWeekNASDAQ:CEMPCempra
28/09/201722h15GlobeNewswire Inc.Cempra and Melinta Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed MergerNASDAQ:CEMPCempra
25/09/201714h00GlobeNewswire Inc.Melinta Therapeutics Presenting Detailed Analyses from Baxdela Phase 3 ABSSSI Trials and In Vitro Performance against Isolate...NASDAQ:CEMPCempra
10/09/201714h45PR Newswire (US)SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Cempra, Inc. -- CEMPNASDAQ:CEMPCempra
07/09/201722h15GlobeNewswire Inc.Cempra Announces Presentations at Upcoming Investor Conferences and Provides Merger Process UpdateNASDAQ:CEMPCempra
07/09/201712h05Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (preliminary) (prem14a)NASDAQ:CEMPCempra
 Showing the most relevant articles for your search:NASDAQ:CEMP